What Painkillers Can I Take With COPD?

Acetaminophen (paracetamol) and topical pain relievers are generally considered the safest first-line painkillers for people with COPD, though even acetaminophen carries some caveats that most patients never hear about. The picture gets more complicated with NSAIDs, opioids, and nerve-pain medications, each of which interacts with COPD in distinct and sometimes dangerous ways. Choosing a painkiller when your lungs are compromised involves trade-offs that go well beyond the usual label warnings.

Why Pain Is Unusually Common in COPD

Before getting into specific drugs, it helps to understand why painkiller questions come up so often for people with COPD. Pain is not just a coincidence in this population. A systematic review and meta-analysis found that pain prevalence in high-quality studies of COPD patients ranged from 32 to 60 percent, with the shoulders, neck, lower back, and chest being the most frequently reported locations.¹ A Norwegian study comparing COPD patients directly with the general population found that 45 percent of COPD patients reported pain versus 34 percent of the general population, with COPD patients experiencing more moderate-to-severe pain in the chest, shoulders, neck, and thorax.²

Some of this pain comes from the disease itself. Hyperinflated lungs press on the chest wall, the diaphragm works harder, and chronic coughing strains muscles and sometimes cracks ribs. Another study found that COPD patients with chest or upper back pain had significantly higher total lung capacity, suggesting that over-inflation of the lungs directly contributes to musculoskeletal pain.³ On top of that, many people with COPD have osteoporosis (partly from long-term corticosteroid use), arthritis, cardiovascular disease, and other conditions that produce their own pain. The result is a population that needs reliable pain relief but has fewer safe options than most people.

Acetaminophen as the Default First Choice

Most clinical guidance points to acetaminophen as the go-to painkiller for COPD patients. A review of analgesic use in people with organ failure described paracetamol and topical agents as the safest first-line options.⁴ The reasoning is straightforward: acetaminophen does not suppress breathing, does not thin the blood, and does not carry the cardiovascular risks of NSAIDs. For mild-to-moderate pain from muscle strain, headaches, or arthritis flares, it remains the least risky systemic option.

That said, the relationship between acetaminophen and lung disease is not perfectly clean. A large observational study found a dose-dependent association between increased acetaminophen use and COPD, as well as reduced lung function. Daily users had roughly 54 mL lower lung function compared to people who never used it.⁵ This does not necessarily mean acetaminophen causes lung damage. People with more pain (possibly from worse lung disease) take more painkillers, so the direction of causation is genuinely unclear. But the finding has been replicated enough times to give researchers pause, and it is worth knowing about if you are taking acetaminophen daily for weeks or months at a time.

There is also a pharmacokinetic wrinkle. A study measuring how COPD patients metabolize common drugs found that the area under the curve for paracetamol (a measure of total drug exposure) was increased by about 60 percent in people with severe COPD compared to healthy controls.⁶ In practical terms, each dose of acetaminophen hangs around longer in your body when your COPD is advanced. The standard maximum dose of acetaminophen is typically set at around 3,000 to 4,000 mg per day for healthy adults, but if your body clears it more slowly, you may reach liver-stress thresholds sooner than expected. This does not mean you should avoid it entirely, but it does mean talking to your doctor about dosing if your lung disease is severe.

NSAIDs and Their Particular Risks

Ibuprofen, naproxen, diclofenac, and other non-steroidal anti-inflammatory drugs are effective painkillers that also reduce inflammation, which makes them tempting for the joint and muscle pain many COPD patients experience. The concern with NSAIDs in COPD is not primarily about the lungs. It is about the heart.

COPD frequently coexists with cardiovascular disease, and NSAIDs raise cardiovascular risk independently. A population-based study found that current NSAID use was associated with a roughly 30 percent higher risk of a first hospital admission for heart failure in the general population. In people with a prior history of heart failure, the risk jumped dramatically.⁷ Since COPD patients already have elevated rates of heart failure and other cardiovascular conditions, adding an NSAID on top compounds an already high baseline risk.

NSAIDs also affect kidney function and can raise blood pressure, both of which matter when you are already on multiple medications. If you have COPD and your doctor has you on diuretics, ACE inhibitors, or other cardiovascular drugs, an NSAID can interfere with how those medications work. Short courses of an NSAID for acute pain, like a badly sprained ankle, may still be appropriate in some patients after a conversation with their prescriber. But regular, ongoing NSAID use is something most COPD guidelines try to steer patients away from.

One additional caveat applies to a smaller subset of patients: aspirin-exacerbated respiratory disease. Some people with asthma or asthma-COPD overlap develop severe bronchospasm when they take aspirin or other NSAIDs. If you have ever had worsening breathing after taking ibuprofen or aspirin, this is a strong reason to avoid the entire NSAID class and discuss alternatives with your doctor.

Opioids and Breathing

Opioids are by far the most anxiety-inducing category for COPD patients and their doctors. The fear is simple: opioids suppress the drive to breathe, and COPD patients already have compromised breathing. The reality is more nuanced than a blanket prohibition, but the risks are real and well-documented.

A large population-based study found that COPD patients prescribed opioids alone had significantly higher all-cause mortality compared to those who were not prescribed opioids or benzodiazepines.⁸ Another study looking specifically at respiratory hospitalizations found that opioid use in the 30 days before an event was associated with a 73 percent higher odds of being hospitalized for a respiratory condition. When opioids and benzodiazepines were used together, the odds more than doubled.⁹

That combination deserves special emphasis. Benzodiazepines (drugs like diazepam, lorazepam, and alprazolam used for anxiety and sleep) suppress breathing through a different mechanism than opioids, and the two together are more dangerous than either alone. Many COPD patients are prescribed benzodiazepines for the anxiety that accompanies chronic breathlessness, which makes the overlap common and the interaction clinically important.

Despite these risks, opioids are not categorically off the table for every COPD patient. Low-dose opioids have been studied specifically for the severe breathlessness that COPD itself causes. A study of low-dose sustained-release oral morphine in COPD patients with severe breathlessness found that side effects were most common during the first week and decreased after that. Most adverse events did not require stopping the medication or reducing the dose.¹⁰ However, a randomized trial testing whether these low doses actually reduced breathlessness found that they did not significantly reduce the intensity of worst breathlessness after one week, concluding that the findings do not support using these doses to relieve breathlessness.¹¹

The practical takeaway for pain rather than breathlessness: if you have COPD and need an opioid for pain that has not responded to other approaches, it is not automatically forbidden. But it requires careful dosing, close monitoring, a slow start, and ideally avoidance of concurrent benzodiazepines. This is a conversation to have with a prescriber who knows your lung function numbers, not a decision to make based on leftover pills in the medicine cabinet.

Gabapentinoids Deserve Separate Attention

Gabapentin and pregabalin are not traditional painkillers, but they are widely prescribed for nerve pain, fibromyalgia, and other chronic pain conditions. Many COPD patients end up on them. Regulatory agencies in North America and Europe have issued warnings about severe breathing problems associated with gabapentinoids, and a large population-based study found that gabapentinoid use in COPD patients was associated with an increased risk of severe exacerbation.¹²

This risk is amplified when gabapentinoids are combined with opioids, which happens frequently in chronic pain management. If you are taking gabapentin or pregabalin for pain and you also have COPD, bring this up with your doctor. They may not have connected the two prescriptions, especially if different specialists wrote them. The exacerbation risk is real enough that it may warrant switching to a different approach to your nerve pain.

How Severe COPD Changes Drug Metabolism

One underappreciated factor in painkiller safety for COPD patients is that the disease itself changes how your body processes medications. The same pharmacokinetic study that found increased acetaminophen exposure in COPD also measured clearance rates for several other drugs metabolized through different liver pathways. The results were striking: oral clearance of midazolam was reduced to 63 percent of normal, losartan to 53 percent, and omeprazole to just 35 percent. This translated to roughly two-fold increases in drug exposure for several medications and a five-fold increase for omeprazole.⁶

The mechanism behind this slowdown involves reduced blood flow to the liver and impaired function of certain liver enzymes in the setting of chronic low oxygen levels. For pain management, the implication is that standard doses of many drugs produce higher-than-expected blood levels in people with advanced COPD. This affects opioids, some NSAIDs, and various co-prescribed medications. It is one reason why “start low and go slow” is not just a cliché but a genuine safety principle for this patient group.

Topical Pain Relief as a Safer Alternative

Topical analgesics get surprisingly little attention considering how much safer they are for COPD patients. Topical NSAIDs (like diclofenac gel), lidocaine patches, capsaicin cream, and menthol-based rubs deliver pain relief to a specific area with minimal systemic absorption. That means you get far less of the drug circulating through your bloodstream, which sidesteps most of the cardiovascular, renal, and respiratory concerns associated with oral painkillers.

For localized pain in the knees, shoulders, hands, or lower back, topical NSAIDs can be as effective as oral NSAIDs for osteoarthritis pain while producing a fraction of the systemic exposure. Lidocaine patches are useful for nerve-related pain in a specific area, such as post-herpetic neuralgia or localized neuropathy. Capsaicin cream, made from chili peppers, works by depleting a pain-signaling chemical in nerve endings and can help with both joint and nerve pain over time, though it burns initially and takes consistent application over several weeks to become effective.

The recommendation of topical agents alongside paracetamol as the safest first-line options across organ failure states reflects a broader clinical recognition that keeping systemic drug exposure low matters most in people whose bodies are already under physiological stress.⁴ If you have COPD and are reaching for ibuprofen tablets every day for a sore knee, switching to topical diclofenac gel applied directly to the joint is worth discussing with your pharmacist or doctor.

What About Pulmonary Rehabilitation for Pain?

Pulmonary rehabilitation programs, which combine supervised exercise, education, and breathing techniques, are a cornerstone of COPD management and improve exercise capacity and quality of life. You might assume that getting fitter and learning to move better would also reduce chronic pain, but a study examining this directly found otherwise. In COPD patients with chronic pain, pulmonary rehabilitation did not significantly affect pain intensity, anxiety, depression, or pain coping strategies.¹³

This does not mean rehab is useless for COPD patients with pain, but it does mean that pain management likely needs its own targeted strategy rather than being expected to improve as a side effect of general conditioning. For some patients, this might look like physical therapy focused specifically on the painful areas, manual therapy, or a combination of topical analgesics and targeted exercise. Relying on pulmonary rehab alone to address significant chronic pain is likely to be disappointing.

The Polypharmacy Problem

Most COPD patients are already taking multiple medications: inhalers, possibly oral corticosteroids, sometimes antibiotics during exacerbations, and often drugs for coexisting conditions like high blood pressure, diabetes, or depression. Adding a painkiller to this mix creates opportunities for drug interactions that neither the patient nor any single prescriber may be fully tracking.

The combination of opioids and benzodiazepines has already been mentioned, but other interactions matter too. Oral NSAIDs can reduce the effectiveness of blood-pressure medications and increase the risk of kidney damage when combined with diuretics. Acetaminophen at high doses interacts with warfarin. Gabapentin and pregabalin add sedation on top of any other sedating medications a patient may be taking. A systematic review of clinical practice guidelines for pain in COPD found that while most guidelines acknowledged pain as a problem, only a minority offered specific treatment recommendations, and those recommendations varied considerably.¹⁴ The lack of consistent guidance means that much of the decision-making falls on individual doctors and patients navigating competing risks.

If you have COPD and chronic pain, one of the most practical things you can do is ensure that one provider has a complete list of every medication you take, including over-the-counter painkillers and supplements. Pharmacy records can help with this, but only if you use the same pharmacy for everything. The risk of a dangerous interaction goes up with every additional prescriber who does not know the full picture.

Self-Medication and What Gets Missed

A significant number of people manage their pain with over-the-counter drugs without consulting a healthcare provider. Research on self-medication patterns in pharmacy settings has found that analgesics are the most commonly purchased over-the-counter drug category, and that a substantial proportion of people take more than the recommended dose or experience drug-related problems.¹⁵ For COPD patients, the risks of self-medicating are magnified by altered drug metabolism, the potential for respiratory depression with certain combinations, and the cardiovascular comorbidities that make NSAID use riskier.

The most common self-medication scenario to worry about is the COPD patient who takes daily over-the-counter ibuprofen for arthritis pain and never mentions it to their pulmonologist, because they do not think of it as a “real” medication. Or the patient who takes acetaminophen-containing cold remedies on top of standalone acetaminophen tablets, not realizing they are doubling up. Acetaminophen is in dozens of combination products, from cold medicines to sleep aids, and the cumulative dose can creep above safe thresholds without anyone noticing, particularly when clearance is already slowed by severe lung disease.

If you have COPD and buy painkillers without a prescription, read the active ingredients on every box. Check whether your cold medicine or nighttime cough syrup already contains acetaminophen before adding more. And mention your over-the-counter painkiller habits to your doctor at least once, even if it feels trivial. In the context of COPD, what seems like a harmless drugstore purchase can quietly shift the risk balance.